This site is intended for Healthcare Professionals only.

Zentiva recalls Co-codamol effervescent tablets

Date:

Share post:

Zentiva Pharma has recalled the batch of Co-codamol 30/500 effervescent tablets as a precautionary measure due to an “issue with the homogeneity of the batch”.

The company said some of the medicines were found to have “too little active ingredients (codeine phosphate and paracetamol) in them”, while “some may contain too much active ingredients”.

As per the current investigation, the tablets were identified where the content of both codeine and paracetamol was less than the label claimed.

The medicine with batch number 1K10121 was distributed first in the month of March this year.

Batch Number Expiry Date Pack Size First Distributed
1K10121 December 2023 100 March 2021

 

With this potential risk to the patients, the regulators advised that healthcare professionals immediately stop supplying the said batch of the medicine and “quarantine all remaining stock” and “return the said batch of tablets to their supplier”. The regulators also suggested to contact all patients who have been dispensed the impacted batch and have asked them to “urgently return the stock to the pharmacy for replacement.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

FIP supports PDA’s Safer Pharmacies Charter

PDA urges all UK pharmacists to take part in the 2024 Safer Pharmacies Survey The International Pharmaceutical Federation...

Topiramate should not be prescribed for epilepsy during pregnancy unless…

MHRA tightens safety measures for topiramate by introducing a new pregnancy prevention programme  Healthcare professionals in the UK are...

WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic

Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States The...

Synnovis cyber attack: NHS patient data leaked, services impacted

The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber...